Specialty Pharmacy Continum: Multiple Sclerosis Generics Switching Program Saves Millions - Prime Therapeutics
In the News
Specialty Pharmacy Continum: Multiple Sclerosis Generics Switching Program Saves Millions
Specialty Pharmacy Continuum: A program in which managed care pharmacists reached out to healthcare providers in 2023 to advise them of potential cost savings that could accrue by switching their patients with multiple sclerosis (MS) from branded to generic therapies has generated significant savings

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.